Tiong Seng Holdings Limited (SGX:BFI)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions SGD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 11, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	45	37	29	42	58	64
Market Cap Growth	29.23%	29.23%	-32.29%	-26.77%	-10.27%	-27.55%
Enterprise Value	105	66	45	70	91	109
Last Close Price	0.10	0.08	0.07	0.10	0.13	0.14
PE Ratio	15.81	12.96	-	-	-	-
Forward PE	-	19.57	19.57	19.57	19.57	19.57
PS Ratio	0.08	0.07	0.06	0.12	0.20	0.27
PB Ratio	0.59	0.48	0.38	0.44	0.30	0.27
P/TBV Ratio	0.62	0.51	0.40	0.46	0.30	0.27
P/FCF Ratio	-	-	0.65	-	-	2.02
P/OCF Ratio	-	-	0.59	-	34.59	1.84
EV/Sales Ratio	0.19	0.12	0.09	0.20	0.31	0.46
EV/EBITDA Ratio	155.80	-	-	-	-	-
EV/FCF Ratio	-2.00	-	1.01	-	-	3.41
Debt / Equity Ratio	1.23	1.23	1.65	1.18	0.48	0.31
Debt / FCF Ratio	-	-	2.81	-	-	2.31
Asset Turnover	1.17	1.17	0.93	0.69	0.55	0.40
Inventory Turnover	4.13	4.13	3.17	2.40	1.61	1.13
Quick Ratio	0.46	0.46	0.56	0.53	0.60	0.59
Current Ratio	1.00	1.00	1.00	1.01	1.26	1.42
Return on Equity (ROE)	3.73%	3.73%	-15.83%	-58.49%	-24.24%	-13.29%
Return on Assets (ROA)	-0.89%	-0.89%	-1.13%	-10.15%	-6.36%	-4.07%
Return on Capital (ROIC)	-2.23%	-2.23%	-2.82%	-20.94%	-11.28%	-6.94%
Earnings Yield	6.33%	7.71%	-42.28%	-200.03%	-86.81%	-49.64%
FCF Yield	-116.08%	-141.57%	153.98%	-53.64%	-10.30%	49.42%
Dividend Yield	-	-	-	-	1.94%	1.77%
Buyback Yield / Dilution	-4.53%	-4.53%	0.06%	0.01%	0.30%	0.46%
Total Shareholder Return	-	-4.53%	0.06%	0.01%	2.25%	2.23%

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.